Literature DB >> 18623071

What goes on behind closed doors: physiological versus pharmacological steroid hormone actions.

S Stoney Simons1.   

Abstract

Steroid-hormone-activated receptor proteins are among the best-understood class of factors for altering gene transcription in cells. Steroid receptors are of major importance in maintaining normal human physiology by responding to circulating concentrations of steroid in the nM range. Nonetheless, most studies of steroid receptor action have been conducted using the supra-physiological conditions of saturating concentrations (> or =100 nM) of potent synthetic steroid agonists. Here we summarize the recent developments arising from experiments using two clinically relevant conditions: subsaturating concentrations of agonist (to mimic the circulating concentrations in mammals) and saturating concentrations of antagonists (which are employed in endocrine therapies to block the actions of endogenous steroids). These studies have revealed new facets of steroid hormone action that could not be uncovered by conventional experiments with saturating concentrations of agonist steroids, such as a plethora of factors/conditions for the differential control of gene expression by physiological levels of steroid, a rational approach for examining the gene-specific variations in partial agonist activity of antisteroids, and a dissociation of steroid potency and efficacy that implies the existence of separate, and possibly novel, mechanistic steps and cofactors. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18623071      PMCID: PMC2742386          DOI: 10.1002/bies.20792

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  114 in total

1.  Transactivation specificity of glucocorticoid versus progesterone receptors. Role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains.

Authors:  L N Song; B Huse; S Rusconi; S S Simons
Journal:  J Biol Chem       Date:  2001-05-01       Impact factor: 5.157

2.  Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor.

Authors:  Xuesen Dong; Oksana Shylnova; John R G Challis; Stephen J Lye
Journal:  J Biol Chem       Date:  2005-01-24       Impact factor: 5.157

3.  Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.

Authors:  Lee Frego; Walter Davidson
Journal:  Protein Sci       Date:  2006-04       Impact factor: 6.725

4.  Thyroid hormone response element organization dictates the composition of active receptor.

Authors:  Lara F R Velasco; Marie Togashi; Paul G Walfish; Rutinéia P Pessanha; Fanny N Moura; Gustavo B Barra; Phuong Nguyen; Rachelle Rebong; Chaoshen Yuan; Luiz A Simeoni; Ralff C J Ribeiro; John D Baxter; Paul Webb; Francisco A R Neves
Journal:  J Biol Chem       Date:  2007-02-20       Impact factor: 5.157

5.  Modulation of transcriptional sensitivity of mineralocorticoid and estrogen receptors.

Authors:  Qi Wang; Sarah Anzick; William F Richter; Paul Meltzer; S Stoney Simons
Journal:  J Steroid Biochem Mol Biol       Date:  2004-08       Impact factor: 4.292

6.  Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor.

Authors:  Rachel R Kroe; Martha A Baker; Martha P Brown; Neil A Farrow; Elda Gautschi; Jerry L Hopkins; Roger R LaFrance; Anthony Kronkaitis; Dorothy Freeman; David Thomson; Gerald Nabozny; Christine A Grygon; Mark E Labadia
Journal:  Biophys Chem       Date:  2007-04-05       Impact factor: 2.352

7.  Mechanism of dexamethasone 21-mesylate antiglucocorticoid action: I. Receptor-antiglucocorticoid complexes do not competitively inhibit receptor-glucocorticoid complex activation of gene transcription in vivo.

Authors:  F D Sistare; G L Hager; S S Simons
Journal:  Mol Endocrinol       Date:  1987-09

8.  A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.

Authors:  Jingwei Cheng; Chen Zhang; David J Shapiro
Journal:  Endocrinology       Date:  2007-07-05       Impact factor: 4.736

9.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  29 in total

1.  An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics.

Authors:  T Joshi; M Johnson; R Newton; M Giembycz
Journal:  Br J Pharmacol       Date:  2015-01-08       Impact factor: 8.739

2.  A theoretical framework for gene induction and experimental comparisons.

Authors:  Karen M Ong; John A Blackford; Benjamin L Kagan; S Stoney Simons; Carson C Chow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 3.  Nongenomic signaling pathways of estrogen toxicity.

Authors:  Cheryl S Watson; Yow-Jiun Jeng; Mikhail Y Kochukov
Journal:  Toxicol Sci       Date:  2009-12-02       Impact factor: 4.849

4.  Structures and mechanism for the design of highly potent glucocorticoids.

Authors:  Yuanzheng He; Wei Yi; Kelly Suino-Powell; X Edward Zhou; W David Tolbert; Xiaobo Tang; Jing Yang; Huaiyu Yang; Jingjing Shi; Li Hou; Hualiang Jiang; Karsten Melcher; H Eric Xu
Journal:  Cell Res       Date:  2014-04-25       Impact factor: 25.617

5.  Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction.

Authors:  Smita Awasthi; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2012-02-11       Impact factor: 4.102

Review 6.  The road less traveled: new views of steroid receptor action from the path of dose-response curves.

Authors:  S Stoney Simons; Carson C Chow
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

7.  PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation.

Authors:  Zhenhuan Zhang; Yunguang Sun; Young-Wook Cho; Carson C Chow; S Stoney Simons
Journal:  J Biol Chem       Date:  2012-11-17       Impact factor: 5.157

8.  A conserved protein motif is required for full modulatory activity of negative elongation factor subunits NELF-A and NELF-B in modifying glucocorticoid receptor-regulated gene induction properties.

Authors:  Min Luo; Xinping Lu; Rong Zhu; Zhenhuan Zhang; Carson C Chow; Rong Li; S Stoney Simons
Journal:  J Biol Chem       Date:  2013-10-06       Impact factor: 5.157

9.  STAMP alters the growth of transformed and ovarian cancer cells.

Authors:  Yuanzheng He; John A Blackford; Elise C Kohn; S Stoney Simons
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

10.  Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling: DEPENDENCE ON DNA SEQUENCE, MR CONFORMATION, AND AP-1 FAMILY MEMBER EXPRESSION.

Authors:  Edward J Dougherty; Jason M Elinoff; Gabriela A Ferreyra; Angela Hou; Rongman Cai; Junfeng Sun; Kevin P Blaine; Shuibang Wang; Robert L Danner
Journal:  J Biol Chem       Date:  2016-09-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.